Liontrust’s has appointed, subject to regulatory approval, Mandy Donald as an Independent Non-executive Director on the firm’s board, effective 1 August 2019. Donald will also become Chairman of the Audit & Risk Committee on 20 September 2019.
Donald has board experience in both complex organisations and early stage environments, and brings a background of strategic planning and operational management to the company. A chartered accountant by training, she spent 18 years with EY before steering her focus towards the growth of new companies, serving on the boards of a diverse range of start-up businesses. Mandy is a Trustee of The Institute of Cancer Research, where she is also Chair of the Audit Committee, she is also a Non-executive Director and Chair of the Audit Committee of Punter Southall Group. Mandy holds a Financial Times Non-Executive Diploma with a focus in corporate governance.
Adrian Collins (pictured), Non-executive Chairman of Liontrust, says: “We welcome Mandy Donald to Liontrust’s Board of Directors and we know she will be a great addition. Mandy brings extensive and valuable experience, having worked with EY for 18 years as well as with a broad range of financial and non-financial entities.
“I and the rest of the Board are looking forward to working with Mandy and to her contribution to the further growth of Liontrust over the coming years.”
